P2.02-019 Lung Cancer in Young Adults (Age Group 18-50 yrs): Presentation, Clinical Features and Treatment

Abstract

Non-small cell lung cancer in young adults appears to be increasing over recent years. It’s a devastating illness both for the patient and their family. It has got significant socioeconomic implications. Data were analyzed for the period between 2010 and 2015 from the University Hospitals of Leicester data base. Young adults were defined as age less than 50 and further sub divided into 18-39 years and 40-50 years of age respectively. Data were extracted regarding the histological diagnosis of cancer, performance status, disease staging and the treatment received. From a total of 93 patient’s we found the majority had adenocarcinoma,with 56% in the 18-39 age group and 63.6% in 40-50 age group. A greater proportion of patients in each age group were found to have a performance status of 0.The number of male patients were noted to be slightly higher between 18 and 39 (55%), compared to the 40-50 age groups, where there was a female predominance (57%). The majority of patients in both age groups were found to have a good performance status and a larger proportion of patient’s eGFR status was negative. Young adults were more likely to have surgery and chemotherapy due to their better performance status. In our cohort of young adults with lung cancer, the majority of patients had a good performance status despite late stage disease. They were likely to be fit for treatment and have longer survival outcomes.